Exception Access Regime – cannabis products and derivatives

Published date01 March 2021
Subject MatterMarijuana,Life Sciences,Regulatory Agenda,Research and Development,Regulatory Reform,Argentina,Pharmaceutical Industry,Plant Based Products,Cannabis Products
AuthorSantiago Oliva Pinto,Josefina Inés Viola
Law FirmDentons

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT